Ultrasonographic intelligent diagnosis and localization of thyroid nodules

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200066755

Enrollment

Unknown

Registered

2022-12-15

Start date

2023-01-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid nodules

Interventions

Gold Standard:Biopsy or surgical pathology results

Index test:The accuracy of artificial intelligence to distinguish between benign and malignant nodules

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Age=18 years old; ? TI-RADS 3 or above thyroid nodules; ? Not received partial or total thyroidectomy; ?FNAC Bethesda II-VI; ? Subjects voluntarily participated in the trial and signed the informed consent.

Exclusion criteria

Exclusion criteria: ? FNAC Bethesda I; ?Bethesda III-V without postoperative histopathology can not be clearly diagnosed as benign or malignant, or clearly diagnosed as metastasis of other cancers; ? Incomplete clinical information (Note: patients with no indication for surgery or who did not receive surgery can be followed up).

Design outcomes

Primary

Measure	Time frame
sensitivity;specifity;accuracy;area under the receiver operating characteristic curve;	—

Countries

China

Contacts

Public ContactLi-ping Sun

Shanghai Tenth People's Hospital

sunliping_s@126.com+86 18616217981

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026